Branke, J;
Farid, SS;
Shah, N;
(2016)
Industry 4.0: a vision for personalized medicine supply chains?
Cell and Gene Therapy Insights
, 2
(2)
pp. 263-270.
10.18609/cgti.2016.027.
Preview |
Text
Farid Branke Shah Industry 4 0 CellGeneTxInsights Accepted.pdf - Accepted Version Download (158kB) | Preview |
Abstract
Industry 4.0 foresees a digital transformation of manufacturing resulting in smart factories and supply chains. At the heart of the concept lies the vision of interconnected materials, goods and machines, where goods find their way through the factory and the supply chain to the customer in a self-organized manner. Industry 4.0 is gaining traction in high value manufacturing sectors. This expert insight article explores what this technology-driven vision has to offer the biopharmaceutical industry, and in particular cell and gene therapies.
| Type: | Article |
|---|---|
| Title: | Industry 4.0: a vision for personalized medicine supply chains? |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.18609/cgti.2016.027 |
| Publisher version: | http://doi.org/10.18609/cgti.2016.027 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | Industry 4.0, Cyber Physical Systems, Internet of Things |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices UCL > Provost and Vice Provost Offices > UCL BEAMS UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Engineering Science UCL > Provost and Vice Provost Offices > UCL BEAMS > Faculty of Engineering Science > Dept of Biochemical Engineering |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10041672 |
Archive Staff Only
 |
View Item |
